Summary:
This podcast features a panel discussion from the 2024 PODD Conference with pharma, medtech and academic leaders about technological development and patient and clinical adoption of closed-loop systems. Specifically:
- Success in diabetes and lessons for other indications like oncology and CNS
- New frontiers in improving closed-loop therapies
- Increasing access across therapy areas
To learn more about the PODD Conference, please visit Drug-Delivery.org.
Moderators
Christopher Kovalchick, PhD
Director, Systems Engineering, Abbott Diabetes Care
Abbott
Panelists
Henrik Bengtsson, E-MBA
Senior Innovation Lead (Director)
Novo Nordisk
Louis DeRidder
PhD Candidate
Harvard Medical School and MIT
Steven J. Russell, MD, PhD
Associate Professor of Medicine, Harvard Medical School
CMO, Beta Bionics
Ben Lane, MS
VP Product Development
Key Tech Inc.
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.